Comments on: "Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity".

More about this publication

Neuro-oncology
  • Volume 22
  • Issue nr. 9
  • Pages 1404-1405
  • Publication date 29-09-2020

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.